Insulatard (isophane insulin) / Novo Nordisk 
Welcome,         Profile    Billing    Logout  

12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Insulatard (isophane insulin) / Novo Nordisk
2004-003887-31: \"Farmakodynamiske egenskaber af to langtidsvirkende insulinanaloger i sammenligning med NPH insulin\"

Ongoing
4
12
Europe
insulin glargine, insulin detemir, insulin human (rDNa), HOE901, NN304, Lantus®, Levemir®, Insulatard®, Lantus®, Levemir®, Insulatard®
Klinisk Farmakologisk Center og Med. Afd. M, Århus Sygehus, NBG
Healthy subjects.
 
 
2005-003877-26: Comparison of the effect of insulin detemir and NPH insulin on dawn phenomenon in patients with Type 1 diabetes An open-labelled, randomised, cross-over, multi-center trial comparing the effect of insulin detemir versus NPH insulin as basal insulins on dawn phenomenon and the glycaemic control in patients with Type 1 diabetes treated on a basal-bolus regimen

Ongoing
4
100
Europe
Levemir, NovoRapid Penfill, Insulatard Penfill, Levemir, NovoRapid Penfill, Insulatard Penfill
National Centre for Diabetes Care, 1st Dept. Medicine, Diabetes Unit
Type 1 diabetes mellitus, dawn phenomenon
 
 
2006-005817-36: Ensayo Clínico en fase IV para la comparación entre dos pautas de tratamiento (insulina humana vs análogos de insulina) respecto al riesgo de hipoglicemia y la variabilidad del control glicémico en pacientes con diabetes mellitus tipo 1: impacto sobre el HYPO score y el LI (lability index).

Ongoing
4
70
Europe
Novorapid Flexpen, Lantus Optiset, Innolet Insulatard, Innolet Actrapid, Novorapid Flexpen, Lantus Optiset, Innolet Insulatard, Innolet Actrapid, Novorapid Flexpen, Lantus Optiset, Innolet Insulatard, Innolet Actrapid
Dr Manuel Pérez Maraver.Servicio de Endocrinologia. Hospital de Bellvitge
Diabetes mellitus tipo 1. Variabilidad del control glicémico y riesgo de hipoglicemia con una pauta de insulina basada en analogos respecto a una con insulina humana.
 
 
2007-003085-17: The effect of insulin detemir on energy balance, postprandial nutrient handling, body fat distribution,and adipose tissue metabolism and gene expression in patients with type 2 diabetes.

Ongoing
4
30
Europe
Levemir, Insulatard, NovoRapid, Levemir, Insulatard, NovoRapid
University of Surrey
Type 2 Diabetes Mellitus
 
 
2011-001642-14`ACTRN12621000158864: The effects of subcutaneous insulin detemir on glucose flux, pharmacokinetics and brain function in type one diabetes

Ongoing
4
16
Europe
Detemir (Levemir®), NPH insulin (Insulatard®), Actrapid, EU/1/04/278/005, EU/1/02/233/003, Actrapid 100 IU/ml EU/1/02/230/003, Insulin detemir, Human insulin NPH insulatard, Insulin actrapid, Insulin detemir, Human insulin NPH insulatard, Insulin actrapid
University of Surrey, Flinders University
Obstructive sleep apnoea
 
 
2011-006179-20: Comparative randomized clinical trial between insulin analogues and human insulin in hospitalized patients treated with artificial tube feeding and who present high blood glucose levels. INSULINE study. Ensayo clínico aleatorizado comparativo entre análogos de insulina e insulina humana en pacientes hospitalizados tratados con alimentación artificial por sonda y que presentan niveles elevados de glucosa en sangre. Estudio INSULINE.

Ongoing
4
100
Europe
Apidra SoloStar, Lantus SoloStar, Actrapid Innolet, Insulatard FlexPen, Apidra SoloStar, Lantus SoloStar, Actrapid Innolet, Insulatard FlexPen
Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge., Endocrinology and Nutrition Unit. Hospital Universitari Bellvitge.
Pacients receiving enteral nutrition and who present hyperglycemia. Pacientes tratados con nutrición enteral y que presenten hiperglicemia.
 
 
2017-002101-35: THE ROLE OF HYPERGLYCEMIA, HYPERINSULINEMIA AND ELEVATED FREE FATTY ACIDS FOR CARDIAC FUNCTION IN PATIENTS WITH TYPE 2 DIABETES

Ongoing
4
20
Europe
Film-coated tablet, Solution for injection in pre-filled pen, Jardiance, Insulatard
Sten Madsbad, Boehringer-Ingelheim Gmbh
typé 2 diabetes, late-onset diabetes, Diseases [C] - Hormonal diseases [C19]
 
 
2017-004454-42: An interventional study to arrest the progression of cognitive decline in diabetic patients at high risk of developing Alzheimer's disease by reducinghypoglycemic events (low blood glucose). Estudio de intervención para detener o frenar la progresión del deteriorocognitivo en pacientes diabéticos con alto riesgo de desarrollar enfermedadde Alzheimer mediante la disminución de las hipoglucemias (niveles deazúcar bajos).

Ongoing
4
188
Europe
GLARGINE, NPH, LANTUS, INSULATARD, Solution for injection in pre-filled pen, Tresiba, Levemir, Lantus, Insulatard
Vall d'Hebron Research Institute, Vall d'Hebron Research Institute
Cognitive decline in patients affected with mild cognitive impairment Se investiga la progresión del deterioro cognitivo en pacientes con deterioro cognitivo incipiente, The progression of a condition named mild cognitive impairment (which antedates dementia) is investigated. Se investiga la progresión del deterioro cognitivo incipiente, que es una condición que antecede a la demencia., Diseases [C] - Nervous System Diseases [C10]
 
 
2018-002640-82: Optimal treatment of glucocorticoid-induced diabetes.

Ongoing
4
74
Europe
Jardiance, Insulatard
Nordsjællands Hospital, independent non-commercial foundations
Diabetes Mellitus that is induced by the use of glucocorticoids, Diabetes due to the use of steroid hormones, Diseases [C] - Hormonal diseases [C19]
 
 
2010-022246-25: Diagnostic clinique et mécanismes physiopathologiques de l'allergie à l'insuline.

Not yet recruiting
3
70
Europe
Actrapid, Insulatard, Insuman Infusat, Humalog, NovoRapid, Apidra, Lantus, Levemir, Latex, Solution for injection, Suspension for injection, Solution for infusion, Actrapid, Insulatard, Novorapid, Levemir
Allergie à l'insuline
 
 
2016-001401-16: The SUGAR-DIP trial: Oral medication versus insulin for diabetes in pregnancy De SUGAR-DIP trial: Orale medicatie versus insuline voor zwangerschapsdiabetes

Ongoing
3
810
Europe
Metformin, Glibenclamide, Tablet, Injection, Metformin, Glibenclamide, Insulin: including - fast acting, analog: NovoRapid, Humalog, Apidra - short acting, human: Actrapid, Humuline Regular, Insuman Rapid - medium long acting, human: Insulatard, Humuline NPH, Insuman Basal - long acting analog: Lantus, Levemir
University Medical Center Utrecht, ZonMw
The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacological treatment. In deze trial wordt het ziektebeeld diabetes gravidarum onderzocht, waarbij er met dieetaanpassingen onvoldoende glucosecontrole is bereikt en er dus indicatie is voor aanvullende farmacologische behandeling., Gestational diabetes, also known as gestational diabetes mellitus, is a condition in which women without previously diagnosed diabetes exhibit high blood glucose (blood sugar) levels during pregnancy. Zwangerschapssuikerziekte, ook wel zwangerschapsdiabetes, is een aandoening waarbij vrouwen waarbij niet al eerder suikerziekte is vastgesteld, tijdens de zwangerschap hoge bloedsuikerwaardes hebben., Diseases [C] - Female diseases of the urinary and reproductive systems and pregancy complications [C13]
 
 
2005-001259-39: An investigation into a novel clinical use of a single low dose of insulin in the prevention of excessive cutaneous scarring

Ongoing
2
15
Europe
Insulatard, Insulatard, Insulatard
West Herts NHS Trust
Normal scarringHypertrophic scarringHypertrophic scarring
 
 

Download Options